Federal Awards · RESILIENCE GOVERNMENT SERVICES, INC. · Award

THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADM…

Research this with AI

Analyze this awardResearch incumbentExplore recompete potential

SmartSolo ChatGPT Claude Perplexity Grok Gemini

Ask AI researches this public topic. CaptureIQ qualifies the opportunity, manages the pursuit, and prepares review-ready materials.

Ready to pursue? Open in CaptureIQ.

Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.

Award details

Award ID: W911SR22F0073
Contractor: RESILIENCE GOVERNMENT SERVICES, INC.
Awarding agency: Department of Defense
Sub-agency / office: Department of the Army
Award amount: $4,861,156
Period of performance: Jun 16, 2022 – Feb 28, 2025
NAICS: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: PSC AN42
Place of performance: ALACHUA, FL, 326158726, USA
Competition: NOT AVAILABLE FOR COMPETITION
Pricing: COST PLUS FIXED FEE
Financial breakdown: Current value $4,861,156 · Obligated $4,459,366 · Potential value $4,861,156 · Latest action obligation $-26,789 · Outlays $94,760
Parent award: W911SR22D0009

Public award description

THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE.

Most recent · Modification P00009 · Sep 12, 2025 · $-26,789 action obligation · THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. · W911SR22F0073

Modification P00008 · Jun 25, 2025 · $0 action obligation · THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. · W911SR22F0073

Modification P00007 · Jun 18, 2025 · $-375,000 action obligation · THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. · W911SR22F0073

Source: USAspending.gov

Related intelligence

Related Federal Awards

Same contractor · W911SR22F0014 — THIS DELIVERY ORDER IS FOR TASKS ASSOCIATED WITH THE DEVELOPMENT OF US FOOD AND DRUG ADMINISTRATION LICENSE… · RESILIENCE GOVERNMENT SERVICES, INC. · Department of Defense · $107,935,344
Same contractor · W911SR23F0057 — DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3,… · RESILIENCE GOVERNMENT SERVICES, INC. · Department of Defense · $9,080,311
Same agency and NAICS · FA945322C0011 — ASSURED SPACE-BASED PNT INNOVATION, RESEARCH & EXPERIMENT (ASPIRE) R&D PROGRAM. IN ACCORDANCE WITH: 10 USC… · CANYON CONSULTING, LLC · Department of Defense · $31,523,489
Same agency and NAICS · FA865022F5408 — MATERIALS RESEARCH AND SURVIVABILITY STUDIES (MARSS) II- INCREMENTAL FUNDING · AZIMUTH CORPORATION · Department of Defense · $19,955,108
Same agency and NAICS · FA865023F6536 — TRAINING AND READINESS TESTBED OPERATIONS · CAE USA INC. · Department of Defense · $7,699,802
Same agency and NAICS · W31P4Q25F0046 — GLOBAL STRIKE RANGE EQUIPMENT AND SYSTEM SUPPORT (GREASS) · GEORGIA TECH APPLIED RESEARCH CORP · Department of Defense · $74,002

Browse federal awards · Browse contractors